IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohrgasse 3, 1030, Vienna, Austria.
Semin Immunopathol. 2010 Jun;32(2):137-48. doi: 10.1007/s00281-010-0197-9. Epub 2010 Feb 21.
Peripheral activation of antigen-specific T cells is stringently controlled to prevent immune responses against self-antigens. Only after a T cell is presented with two signals, an antigen and a co-stimulatory signal, can they be fully activated. In case antigen presentation occurs without co-stimulation, T-cell receptor (TCR) signaling pathways are regulated to prevent T-cell activation and induce T-cell tolerance. Thus, for a productive T-cell response to occur, co-stimulatory receptors need to serve the dual role of amplifying the TCR signaling while concomitantly releasing T cells from suppression. Biochemical and genetic studies during the last 10 years have documented the critical role of the E3 ubiquitin-ligase Cbl-b in this fundamental two-signal modulation of T-cell responses. In this review, we will discuss our current understanding on how Cbl-b controls T-cell activation and tolerance, its in vivo implications, as well as mechanisms for tuning T-cell-mediated immune responses by this essential E3 ligase.
外周激活抗原特异性 T 细胞受到严格控制,以防止针对自身抗原的免疫反应。T 细胞只有在接受两种信号,即抗原和共刺激信号后,才能被完全激活。如果抗原呈递没有共刺激,则调节 T 细胞受体 (TCR) 信号通路以防止 T 细胞激活并诱导 T 细胞耐受。因此,为了发生有效的 T 细胞反应,共刺激受体需要发挥双重作用,即放大 TCR 信号,同时从抑制中释放 T 细胞。在过去 10 年中的生化和遗传研究已经证明了 E3 泛素连接酶 Cbl-b 在这种基本的 T 细胞反应的双信号调节中的关键作用。在这篇综述中,我们将讨论我们目前对 Cbl-b 如何控制 T 细胞激活和耐受的理解,其在体内的意义,以及这种必需的 E3 连接酶调节 T 细胞介导的免疫反应的机制。